YUR-22079-61949
2 vaccinations
0 coded responses
6 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 273 / NC
- Registered
- 2021-12-20
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-10
Dose 1 — Janssen/Johnson & Johnson
-
2021-12-20
Registered in v-safe
-
2021-12-20
Dose 2 — Pfizer-BioNTech
- 2021-12-20
-
2021-12-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-12-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Headache · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2021-12-22
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-12-23
- 2021-12-23
-
2021-12-23
Call successfulParticipant prefers to complete VAERS report online
- 2021-12-24
- 2021-12-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-10 | Janssen/Johnson & Johnson | No |
| 2 | 2021-12-20 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-22 | Successful 2021-12-23 |
Participant prefers to complete VAERS report online |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.